Baidu
map

IDSA指南:抗菌素耐药革兰氏阴性菌感染的治疗(V 2.0)

2021-11-22 美国感染病学会 美国感染病学会官网

美国传染病学会 (IDSA) 致力于为耐药性感染的治疗提供最新的指导。先前的指导文件侧重于由产超广谱 β-内酰胺酶的肠杆菌 (ESBL-E)、耐碳青霉烯类肠杆菌 (CRE) 和难治性铜绿假单

中文标题:

IDSA指南:抗菌素耐药革兰氏阴性菌感染的治疗(V 2.0)

发布机构:

美国感染病学会

发布日期:

2021-11-22

简要介绍:

美国传染病学会 (IDSA) 致力于为耐药性感染的治疗提供最新的指导。先前的指导文件侧重于由产超广谱 β-内酰胺酶的肠杆菌 (ESBL-E)、耐碳青霉烯类肠杆菌 (CRE) 和难治性铜绿假单胞菌 (DTR- . aeruginosa ) 引起的感染。本文提供了治疗产 AmpC β-内酰胺酶的肠杆菌 (AmpC-E)、耐碳青霉烯类鲍曼不动杆菌(CRAB) 和嗜麦芽窄食单胞菌感染的指南。

相关资料下载:
[AttachmentFileName(sort=1, fileName=IDSA指南:抗菌素耐药革兰氏阴性菌感染的治疗(V 2.0).pdf)] GetToolGuiderByIdResponse(projectId=1, id=f22d61c00239e9d2, title=IDSA指南:抗菌素耐药革兰氏阴性菌感染的治疗(V 2.0), enTitle=, guiderFrom=美国感染病学会官网, authorId=0, author=, summary=美国传染病学会 (IDSA) 致力于为耐药性感染的治疗提供最新的指导。先前的指导文件侧重于由产超广谱 &beta;-内酰胺酶的肠杆菌 (ESBL-E)、耐碳青霉烯类肠杆菌 (CRE) 和难治性铜绿假单, cover=https://img.medsci.cn/2022329/1648527081424_1608702.jpg, journalId=0, articlesId=null, associationId=61, associationName=美国感染病学会, associationIntro=美国感染病学会(IDSA)是面向专门从事传染病的医生、科学家和其他医护人员的学会。 核心宗旨是:为临床增加可靠性证据,促进分享以减少传染病给社会带来的经济负担,促进学会成员与其他专业同事之间的合作与交流。, copyright=0, guiderPublishedTime=Mon Nov 22 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #363636;"><span>美国传染病学会 (IDSA) 致力于为耐药性感染的治疗提供最新的指导。</span><span>先前的指导文件侧重于由产超广谱 &beta;-内酰胺酶的肠杆菌 (ESBL-E)、耐碳青霉烯类肠杆菌 (CRE) 和</span><span>难治性铜绿假单胞菌 (DTR-&nbsp;</span></span><em style="color: #363636;"><span>P&nbsp;</span></em><em style="color: #363636;"><span>. aeruginosa</span></em><span style="color: #363636;"><span>&nbsp;) 引起的感染。</span><span>本文提供了治疗产 AmpC &beta;-内酰胺酶的肠杆菌 (AmpC-E)、耐碳青霉烯类</span></span><em style="color: #363636;"><span>鲍曼不动杆菌</span></em><span style="color: #363636;"><span>(CRAB) 和</span></span><em style="color: #363636;"><span>嗜麦芽窄食单胞菌</span></em><span style="color: #363636;"><span>感染的指南。</span></span></p>, tagList=[TagDto(tagId=26540, tagName=细菌组), TagDto(tagId=125066, tagName=抗菌素耐药革兰氏阴性菌)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4058, appHits=164, showAppHits=0, pcHits=565, showPcHits=3894, likes=2, shares=36, comments=2, approvalStatus=1, publishedTime=Tue Mar 29 15:47:00 CST 2022, publishedTimeString=2021-11-22, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Tue Mar 29 12:13:40 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Fri Jan 05 14:18:35 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=IDSA指南:抗菌素耐药革兰氏阴性菌感染的治疗(V 2.0).pdf)])
IDSA指南:抗菌素耐药革兰氏阴性菌感染的治疗(V 2.0).pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1228685, encodeId=c271122868532, content=已分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db7d8216545, createdName=ms7000000406997481, createdTime=Sun Jun 26 07:34:32 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207103, encodeId=d93b120e10374, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c40a6387446, createdName=ms3000000376140643, createdTime=Wed Mar 30 07:30:57 CST 2022, time=2022-03-30, status=1, ipAttribution=)]
    2022-06-26 ms7000000406997481

    已分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1228685, encodeId=c271122868532, content=已分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db7d8216545, createdName=ms7000000406997481, createdTime=Sun Jun 26 07:34:32 CST 2022, time=2022-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207103, encodeId=d93b120e10374, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c40a6387446, createdName=ms3000000376140643, createdTime=Wed Mar 30 07:30:57 CST 2022, time=2022-03-30, status=1, ipAttribution=)]
    2022-03-30 ms3000000376140643

    学习学习

    0

Baidu
map
Baidu
map
Baidu
map